Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;20(9):1054-1060.
doi: 10.1038/gim.2017.210. Epub 2018 Jan 4.

Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework

Affiliations

Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework

Sean V Tavtigian et al. Genet Med. 2018 Sep.

Abstract

Purpose: We evaluated the American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) variant pathogenicity guidelines for internal consistency and compatibility with Bayesian statistical reasoning.

Methods: The ACMG/AMP criteria were translated into a naive Bayesian classifier, assuming four levels of evidence and exponentially scaled odds of pathogenicity. We tested this framework with a range of prior probabilities and odds of pathogenicity.

Results: We modeled the ACMG/AMP guidelines using biologically plausible assumptions. Most ACMG/AMP combining criteria were compatible. One ACMG/AMP likely pathogenic combination was mathematically equivalent to pathogenic and one ACMG/AMP pathogenic combination was actually likely pathogenic. We modeled combinations that include evidence for and against pathogenicity, showing that our approach scored some combinations as pathogenic or likely pathogenic that ACMG/AMP would designate as variant of uncertain significance (VUS).

Conclusion: By transforming the ACMG/AMP guidelines into a Bayesian framework, we provide a mathematical foundation for what was a qualitative heuristic. Only 2 of the 18 existing ACMG/AMP evidence combinations were mathematically inconsistent with the overall framework. Mixed combinations of pathogenic and benign evidence could yield a likely pathogenic, likely benign, or VUS result. This quantitative framework validates the approach adopted by the ACMG/AMP, provides opportunities to further refine evidence categories and combining rules, and supports efforts to automate components of variant pathogenicity assessments.

Keywords: Bayesian framework; medical genetics; unclassified variants; variant classification; variants of uncertain significance.

PubMed Disclaimer

Conflict of interest statement

Competing Interests:

SVT, MSG, and KMB: none, RLN receives salary and equity from Invitae Corp., serves as Chair of the Rare Disease Therapeutic Area Scientific Review Panel for Pfizer Corp., and is on the Advisory Board of Genome Medical. LGB is an uncompensated advisor for the Illumina Corp.

Figures

Figure 1
Figure 1
Permissible solutions to Likely Pathogenic (LP) and Likely Benign (LB) equations. X–Y Combinations of Prior probability of pathogenicity (Prior_P) and Odds very strong (OVst) lying to the right of the blue curve satisfy combining rules Likely Pathogenic (ii–vi). X–Y combinations of Prior_P and OVst lying to the left of the red curve satisfy the Likely Benign combining rule (ii). Values between the two curves and above their intersection at (Prior_P=0.25, OVst=81) simultaneously meet LP and LB criteria. Values outside of the two curves and below their intersection at (Prior_P=0.25, OVst=81) meet neither LP nor LB criteria. The black triangle marks the minimum simultaneous solution of LP and LB at Prior_P=0.25, OVst=81. The black circle marks the solution of LP and LB at Prior_P=0.10, OVst=350 illustrated in Table 1.

References

    1. Plon SE, Eccles DM, Easton D, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282–1291. - PMC - PubMed
    1. Goldgar DE, Easton DF, Deffenbaugh AM, et al. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet. 2004;75:535–544. - PMC - PubMed
    1. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. - PMC - PubMed
    1. Abkevich V, Zharkikh A, Deffenbaugh AM, et al. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet. 2004;41:492–507. - PMC - PubMed
    1. Easton DF, Deffenbaugh AM, Pruss D, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet. 2007;81:873–883. - PMC - PubMed

Publication types